Advancing Alzheimer's Treatment Means Using The Best Biomarker(s) — But Which?
Clinical Leader,
By Frederick Huie, MD, SYNAPS Dx advisory council member, and Emmanuel C. Gorospe, MD, MPH, CPI, FACP, chief medical officer…
Addressing Misdiagnoses, Ensuring Accurate Diagnosis to Inform Appropriate Prescribing and Treatment for Alzheimer Disease
Pharmacy Times,
Symptoms of dementia can be difficult to differentiate from typical age-related behavior changes and other common and…
Who is Really a Candidate for New Drugs to Treat Alzheimer Disease?
Pharmacy Times,
It’s time to cut through the noise on coverage decisions and restricted access to new drugs for Alzheimer disease (AD)—lecanemab…
Identifying Risk Factors for Alzheimer Disease: Are They Modifiable?
Clinical Advisor,
Alzheimer disease (AD) is the most common cause of dementia and represents the most frequently diagnosed neurodegenerative…